Issn Print: 0007-0963
Publication Date: 2017/10/01
A 5‐year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal
S. Weidinger; H. Baurecht; J. Schmitt
Author Information: Department of Dermatology, Venereology and Allergy
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.